Led Accro Bioscience's $50M Series C to advance its immune-mediated disease pipeline.
Accropeutics is dedicated to the discovery and development of innovative drugs for inflammation, autoimmune diseases and cancer, focusing on the 'Cell Death - Inflammation' loop and utilizing a unique 'Regulated Cell Death' drug discovery platform
Accropeutics is dedicated to the discovery and development of innovative drugs for inflammation, autoimmune diseases and cancer, focusing on the 'Cell Death - Inflammation' loop and utilizing a unique 'Regulated Cell Death' drug discovery platform.